Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zimberelimab Combined With Metformin in the Treatment of Recurrent Ovarian Clear Cell Carcinoma: A Pilot Study

NCT05759312 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05759312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zimberelimab Combined With Metformin in the Treatment of Recurrent Ovarian Clear Cell Carcinoma: A Pilot Study
Lead sponsor
Fudan University
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2023
Completion date
February 28, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian clear cell carcinoma